PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $53,000 | -59.5% | 18,708 | -51.4% | 0.01% | -52.4% |
| Q3 2017 | $131,000 | +29.7% | 38,458 | +19.6% | 0.02% | -22.2% |
| Q2 2016 | $101,000 | -52.1% | 32,160 | -49.0% | 0.03% | -52.6% |
| Q1 2016 | $211,000 | +36.1% | 63,119 | +44.4% | 0.06% | +21.3% |
| Q4 2015 | $155,000 | +56.6% | 43,705 | +210.7% | 0.05% | +9.3% |
| Q1 2015 | $99,000 | – | 14,067 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |